Report cover image

Global Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20355393

Description

Summary

According to APO Research, The global Haemophilus Influenzae Type B Injection Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Haemophilus Influenzae Type B Injection Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Haemophilus Influenzae Type B Injection Vaccine include Bharat Biotech, Biokangtai, Glaxosmithkline, Olymvax, Sanofi Pasteur, Walvax Biotechnology, Beijing Minhai Biotechnology Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Chengdu Oulin Biotechnology Co., Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Haemophilus Influenzae Type B Injection Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Haemophilus Influenzae Type B Injection Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Haemophilus Influenzae Type B Injection Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Haemophilus Influenzae Type B Injection Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Haemophilus Influenzae Type B Injection Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Haemophilus Influenzae Type B Injection Vaccine sales, projected growth trends, production technology, application and end-user industry.

Haemophilus Influenzae Type B Injection Vaccine Segment by Company

Bharat Biotech
Biokangtai
Glaxosmithkline
Olymvax
Sanofi Pasteur
Walvax Biotechnology
Beijing Minhai Biotechnology Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Chengdu Oulin Biotechnology Co., Ltd
Chengdu Institute of Biological Products Co., Ltd
Lanzhou Institute of Biological Products Co., Ltd
Yuxi Watson Biotechnology Co., Ltd
Haemophilus Influenzae Type B Injection Vaccine Segment by Type

Lyophilized
Non-lyophilized
Haemophilus Influenzae Type B Injection Vaccine Segment by Application

Hospital
Clinic
Haemophilus Influenzae Type B Injection Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Injection Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Injection Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Injection Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Haemophilus Influenzae Type B Injection Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Injection Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Haemophilus Influenzae Type B Injection Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Haemophilus Influenzae Type B Injection Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Haemophilus Influenzae Type B Injection Vaccine Market Size, 2020 VS 2024 VS 2031
1.3 Global Haemophilus Influenzae Type B Injection Vaccine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Haemophilus Influenzae Type B Injection Vaccine Sales Estimates and Forecasts (2020-2031)
1.5 Global Haemophilus Influenzae Type B Injection Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Haemophilus Influenzae Type B Injection Vaccine Market Dynamics
2.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
2.2 Haemophilus Influenzae Type B Injection Vaccine Industry Drivers
2.3 Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges
2.4 Haemophilus Influenzae Type B Injection Vaccine Industry Restraints
3 Haemophilus Influenzae Type B Injection Vaccine Market by Manufacturers
3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Manufacturers (2020-2025)
3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Manufacturers (2020-2025)
3.3 Global Haemophilus Influenzae Type B Injection Vaccine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Haemophilus Influenzae Type B Injection Vaccine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Haemophilus Influenzae Type B Injection Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers, Product Type & Application
3.7 Global Haemophilus Influenzae Type B Injection Vaccine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Haemophilus Influenzae Type B Injection Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Haemophilus Influenzae Type B Injection Vaccine Players Market Share by Revenue in 2024
3.8.3 2024 Haemophilus Influenzae Type B Injection Vaccine Tier 1, Tier 2, and Tier 3
4 Haemophilus Influenzae Type B Injection Vaccine Market by Type
4.1 Haemophilus Influenzae Type B Injection Vaccine Type Introduction
4.1.1 Lyophilized
4.1.2 Non-lyophilized
4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type
4.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Type (2020-2031)
4.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Type (2020-2031)
4.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type
4.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Type (2020-2031)
4.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Type (2020-2031)
5 Haemophilus Influenzae Type B Injection Vaccine Market by Application
5.1 Haemophilus Influenzae Type B Injection Vaccine Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application
5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Application (2020-2031)
5.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Application (2020-2031)
5.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application
5.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Application (2020-2031)
5.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Application (2020-2031)
6 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region
6.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2020-2031)
6.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2020-2025)
6.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region
7.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region
7.1.1 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2020-2025)
7.1.3 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Region (2026-2031)
7.1.4 Global Haemophilus Influenzae Type B Injection Vaccine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Haemophilus Influenzae Type B Injection Vaccine Revenue (2020-2031)
7.2.2 North America Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue (2020-2031)
7.3.2 Europe Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue (2020-2031)
7.4.2 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Bharat Biotech
8.1.1 Bharat Biotech Comapny Information
8.1.2 Bharat Biotech Business Overview
8.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.1.5 Bharat Biotech Recent Developments
8.2 Biokangtai
8.2.1 Biokangtai Comapny Information
8.2.2 Biokangtai Business Overview
8.2.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.2.5 Biokangtai Recent Developments
8.3 Glaxosmithkline
8.3.1 Glaxosmithkline Comapny Information
8.3.2 Glaxosmithkline Business Overview
8.3.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.3.5 Glaxosmithkline Recent Developments
8.4 Olymvax
8.4.1 Olymvax Comapny Information
8.4.2 Olymvax Business Overview
8.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.4.5 Olymvax Recent Developments
8.5 Sanofi Pasteur
8.5.1 Sanofi Pasteur Comapny Information
8.5.2 Sanofi Pasteur Business Overview
8.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.5.5 Sanofi Pasteur Recent Developments
8.6 Walvax Biotechnology
8.6.1 Walvax Biotechnology Comapny Information
8.6.2 Walvax Biotechnology Business Overview
8.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.6.5 Walvax Biotechnology Recent Developments
8.7 Beijing Minhai Biotechnology Co., Ltd
8.7.1 Beijing Minhai Biotechnology Co., Ltd Comapny Information
8.7.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
8.7.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
8.8 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
8.8.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Comapny Information
8.8.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
8.8.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.8.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
8.9 Chengdu Oulin Biotechnology Co., Ltd
8.9.1 Chengdu Oulin Biotechnology Co., Ltd Comapny Information
8.9.2 Chengdu Oulin Biotechnology Co., Ltd Business Overview
8.9.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.9.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments
8.10 Chengdu Institute of Biological Products Co., Ltd
8.10.1 Chengdu Institute of Biological Products Co., Ltd Comapny Information
8.10.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
8.10.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.10.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
8.11 Lanzhou Institute of Biological Products Co., Ltd
8.11.1 Lanzhou Institute of Biological Products Co., Ltd Comapny Information
8.11.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
8.11.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.11.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
8.12 Yuxi Watson Biotechnology Co., Ltd
8.12.1 Yuxi Watson Biotechnology Co., Ltd Comapny Information
8.12.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
8.12.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
8.12.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Haemophilus Influenzae Type B Injection Vaccine Value Chain Analysis
9.1.1 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Haemophilus Influenzae Type B Injection Vaccine Production Mode & Process
9.2 Haemophilus Influenzae Type B Injection Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
9.2.3 Haemophilus Influenzae Type B Injection Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.